MAPT and Alzheimer disease: The phenotype of AD and non-AD tauopathies aligns with the distribution of neurofibrillary lesions, and the severity of impairment is tied to the amount of tau pathology present (Dickson et al., 2011; Josephs et al., 2011; Nelson et al., 2012).